CoChat

Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response

Open access
Murrough, James W., Wan, Le-Ben, Iacoviello, Brian, Collins, Katherine A., Solon, Carly, Glicksberg, Benjamin, Perez, Andrew M., Mathew, Sanjay J., Charney, Dennis S., Iosifescu, Dan V., Burdick, Katherine E. · 2014 · Psychopharmacology
Cited by 108

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

The N-methyl-d-aspartate (NMDA) glutamate receptor antagonist ketamine has demonstrated rapid antidepressant effects in patients with treatment-resistant depression (TRD). Despite the promise of a novel and urgently needed treatment for refractory depression, concerns regarding potential adverse neurocognitive effects of ketamine remain. Although extensive research has been conducted in healthy volunteers, there is a paucity of studies examining the neurocognitive effects of ketamine in depressed patients. Therefore, the aims of the current study were to characterize the relationship between baseline neurocognition and antidepressant response to ketamine, measure the acute impact of ketamine on neurocognition, and investigate the relationship between acute neurocognitive effects of ketamine and antidepressant response. Neurocognitive functioning was assessed in 25 patients with TRD using a comprehensive battery: estimated premorbid intelligence quotient (IQ), current IQ, and tests from the MATRICS Consensus Cognitive Battery (MCCB). A subset of the MCCB was repeated immediately following a 40-min intravenous infusion of ketamine (0.5 mg/kg). Patients who responded to ketamine 24 h following treatment had poorer baseline neurocognitive performance relative to nonresponders and, in particular, slower processing speed (F = 8.42; df = 23; p = 0.008). Ketamine was associated with selective impairments in memory recall, and the degree of cognitive change carried negative prognostic significance (e.g., negative cognitive effects immediately after ketamine predicted lower response rate at 24 h; Fisher's exact test two-sided p = 0.027). Taken together, our findings suggest a potential baseline neurocognitive predictor of ketamine response and an inverse relationship between the cognitive effects of ketamine and antidepressant efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00213-013-3255-x

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 108

Metadata

Authors
Murrough, J. W., Wan, L.-B., Iacoviello, B., Collins, K. A., Solon, C., Glicksberg, B., Perez, A. M., Mathew, S. J., Charney, D. S., Iosifescu, D. V., & Burdick, K. E.
Venue
Psychopharmacology
Published
2013-09-11
Volume
231
Issue
3
Pages
481-488
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2037792618
Cited by
108
References
19
FWCI
5.86
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. https://app.cochat.ai/papers/10.1007/s00213-013-3255-x
The paper
Murrough, J. W., Wan, L.-B., Iacoviello, B., Collins, K. A., Solon, C., Glicksberg, B., Perez, A. M., Mathew, S. J., Charney, D. S., Iosifescu, D. V., & Burdick, K. E. (2014). Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. Psychopharmacology. https://doi.org/10.1007/s00213-013-3255-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.